Fezolamine

TargetMol
Product Code: TAR-T68070
Supplier: TargetMol
CodeSizePrice
TAR-T68070-1mg1mg£160.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T68070-5mg5mg£279.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T68070-10mg10mg£384.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T68070-25mg25mg£595.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T68070-50mg50mg£816.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T68070-100mg100mg£1,083.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T68070-500mg500mg£2,103.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C

Images

1 / 1

Further Information

Bioactivity:
Fezolamine is a novel orally available non-tricyclic compound with antidepressant activity. It is three to two times more selective in blocking synaptosomal uptake of [3H]norepinephrine than uptake of [4H]3-hydroxytryptamine or [3H]dopamine in vitro. It blocked the inhibitory effects of rifampicin and tetraphenyl in classical behavioral tests using monoamine-depleted animals.
CAS:
80410-36-2
Molecular Weight:
305.42
Pathway:
Neuroscience
Purity:
0.9985
SMILES:
N1=C(C=2C=CC=CC2)C(=CN1CCCN(C)C)C=3C=CC=CC3
Target:
Norepinephrine

References

Baizman ER, et al. Pharmacologic profile of fezolamine fumarate: a nontricyclic antidepressant in animal models. J Pharmacol Exp Ther. 1987;243(1):40-54. McCoy L, et al. Determination of fezolamine and its desmethyl metabolite in human plasma and urine by high-performance liquid chromatography. Intravenous pharmacokinetics in the beagle hound. J Chromatogr. 1985;344:211-220. Zisook S, et al. Efficacy and safety of fezolamine in depressed patients. Neuropsychobiology. 1987;17(3):133-138.